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Background: Ursodeoxycholic acid is an important clinical drug in the treatment of liver disease. In our previous
work, ursodeoxycholic acid was prepared by electroreduction of 7-ketolithocholic acid. The separation of
ursodeoxycholic acid from the electroreduction product (47% (w/w) ursodeoxycholic acid) by silylation
crystallization is described herein.
Results: N,N-dimethylformamide was used as the solvent, whereas hexamethyldisilazane was the reaction agent.
The optimal material ratio of electroreduction product/N,N-dimethylformamide/hexamethyldisilazane was found to
be 1:10:2 (w/v/v). The reaction proceeded for 2 h at 60°C, and the corresponding silylation derivative was separated
by crystallization and pure ursodeoxycholic acid was recovered by 5% acid hydrolysis at 50°C for 0.5 h. The
maximum recovery and purity of ursodeoxycholic acid were 99.8% and 99.5%, respectively.
Conclusion: Ursodeoxycholic acid with high purity and high recovery can be prepared directly. The developed
method offers a potential application for large-scale production of ursodeoxycholic acid.
Keywords: Ursodeoxycholic acid; Silylation; SeparationBackground
Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-cholanic acid,
UDCA) is an important clinical drug used in the treat-
ment of liver disease, such as gallstones [1], alcoholic fatty
liver [2], nonalcoholic fatty liver [3], viral hepatitis [4],
primary biliary cirrhosis [5], primary sclerosing cholangitis
[6], and cholestatic [7].
UDCA was originally separated from the black bear
[8]. In our previous work, UDCA was prepared by elec-
troreduction of 7-ketolithocholic acid (3α-hydroxy-7-
oxo-5β-cholanic acid, 7K-LCA) [9]. UDCA and its
epimer chenodeoxycholic acid (3α, 7α-2-hydroxy-5β-
cholanic acid, CDCA) were both reduction products of
7K-LCA; thus, the product of this electrochemistry
conversion was a mixture of 7K-LCA, UDCA, and CDCA,
which are difficult to separate. This problem limits its
application in the production of UDCA. The structures of
UDCA, 7K-LCA, and CDCA are shown in Figure 1.* Correspondence: caoxj@ecust.edu.cn
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in any medium, provided the original work is pResearchers have focused on the separation and puri-
fication of UDCA. Guillemette et al. [10] described the
purification of UDCA by reacting an aqueous alkali
metal salt solution of UDCA in the presence of chloro-
form with an acid to recover crystalline UDCA. Bonaldi
et al. [11] prepared high-purity UDCA, starting from
cholic acid by forming the tris-trimethylsilyl derivative
acid thereof, reducing the acid by the Wolff-Kishner
method into UDCA, and the total impurities were less
than 1.3%. Xu et al. [12] separated UDCA from its iso-
meric mixture using a core-shell molecular imprinting
polymer, and the separation factor of the molecular
imprinting polymer with acrylamide for UDCA was
2.20. Tian et al. [9] produced UDCA by catalytic trans-
fer hydrogenation of 7K-LCA with Raney nickel, then
UDCA was purified by column chromatography and
recrystallized. Ninety-seven percent UDCA was obtained
via this last method.n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 The structure of UDCA, 7K-LCA, and CDCA. (a) UDCA,
(b) 7K-LCA, and (c) CDCA.
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tion process and the quality of the product in modern
pharmaceutical and organic synthesis, and has been
applied in increasing the volatility [13], changing the
solubility in organic solvents [14], and the protection
of sensitive functional groups such as hydroxyl and
carboxyl moieties [15]. Silylation of alcohols and phe-
nols with hexamethyldisilazane (HMDS) has been
achieved using various types of catalysts [16-21]. The
reaction conditions were nearly neutral, and the corre-
sponding silyl ethers yields were high. Mormann et al.
[22] reported the silylation of cellulose by HMDS in
liquid ammonia and the reaction gave high degrees of
silylation.
In this work, UDCA was isolated from the electro-
reduction product with analogues by silylation
crystallization and UDCA. The process afforded UDCA
with high purity and high recovery via a direct method.Methods
General methods
The standard samples of UDCA, CDCA, and silylating re-
agents were purchased from Aladdin Chemistry Co. Ltd
(Shanghai, China). 7K-LCA was prepared according to our
previous work [9]. Acetonitrile and methanol were of high-
performance liquid chromatography (HPLC) grade and
purchased from Shanghai Xingke Biochemistry Co. Ltd
(Shanghai, China). All other reagents were of analytical
grade. HPLC (LC-20A, Shimadzu Corporation, Kyoto,
Japan) with a UV detector (SPD-20A) using a C18
column (Welchrom-C18, 4.6 × 150 mm, 5 μm, Welch
Materials Inc. Shanghai, China) was used for quantifica-
tion of the reaction products. Electron impact ionization
time-of-flight mass spectrometry (EI-TOF-MS) (Micro-
mass GCTTM, Micromass UK Ltd, Lancas, UK) and
Fourier transform infrared spectroscopy (FTIR)
(Magna-IR 550, Thermo Nicolet Ltd, Wisconsin, USA)
were used for the characterization of the product and
provided by the Analysis and Test Center, East China
University of Science and Technology.
Analytical methods
(1) HPLC was used to analyze the product. The mobile
phase was a mixture of phosphate acid buffer
(pH 3.0) and acetonitrile (50:50, v/v) at a flow rate of
1.0 ml/min at 25°C. Detection was performed using
a UV detector at 208 nm. UDCA was quantified by
an external standard.
(2) EI-TOF-MS was used to identify the molecular
weight of the derivatives.
(3) FTIR spectra with KBr pellets were used to analyze
the structure of the product and the standard
UDCA.
Preparation of UDCA
The synthesis procedure followed Yuan's method [23].
UDCA was synthesized in a divided electrolytic cell by
direct electroreduction of 7K-LCA. A titanium ruthe-
nium mesh electrode was used as the anode, and a
high-purity lead plate was used as the cathode. Under
the optimized process conditions, the content of UDCA
was 47%.
Silylation crystallization
Silylation crystallization experiments were carried out
as below. One gram of the electroreduction product
(47% (w/w) of UDCA) was added into a 100-ml conical
flask containing 10 ml N,N-dimethylformamide (DMF)
at 30°C, and following the dissolution of the material
under magnetic stirring at 150 rpm, 1 ml of HMDS was
added into the solution. The conical flask was sealed
with thread seal tape. The reaction was carried out for
Scheme 1 The reaction formula of silylation and hydrolysis. (a) The silylation reaction formula. (b) The hydrolysis reaction formula. The
different silylation derivatives, effects of silylation reagent types, temperature, and material ratio were measured.
Figure 2 Selection of the silylating reagents. Temperature 30°C,
1 g electroreduction product, 10 ml DMF, and 1 ml TMCS (1 ml
HMDS or 1 g BSU).
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was complete, the flask was moved to glacial water and
maintained at 0°C for 24 h. The crystalline material was
collected by filtration and washed with the same sily-
lating reagent and dried in a vacuum oven.
The silylation derivative of UDCA was then added to
a 5% solution of hydrochloric acid, and the suspension
was warmed to 50°C for 0.5 h. After being cooled, the
precipitate was collected by filtration, then washed with
deionized water and dried in a vacuum oven. The
recovery and purity of the product were measured. The
reaction formula is shown in Scheme 1.
Results and discussion
Selection of silylating reagents
There are many kinds of silylation reagents. In this study,
hexamethyldisilazane (HMDS), trimethylchlorosilane (TMCS),
and 1,3-bis (trimethylsilyl) urea (BSU) were chosen as
the silylating reagents.
The effect of different silylating reagents on UDCA
recovery and purity is presented in Figure 2. These results
indicate that the silylating reagent has an important effect
on the recovery and purity of UDCA. In this study, when
HMDS was used as the silylating reagent, maximal
recovery and purity of UDCA were achieved with values
of 87.7% and 90.4%, respectively.Since the boiling point of TMCS is 57.7°C, the reaction
took place intensively after TMCS was added to the
system under the experimental temperature (30°C), and
TMCS evaporated. Consequently, the contact between re-
actants was reduced, and this made the final product yield
Figure 3 Influence of different temperatures on silylation.
1 g electroreduction product, 10 ml DMF, and 1 ml HMDS.
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solubility of the derivative of UDCA in DMF, so it is
difficult to form a precipitant. HMDS, the commer-
cially available reagent for trimethylsilylation of reac-
tive hydrogen, is stable and yields ammonia as the only
by-product, which is simple to remove from the reac-
tion medium. Therefore, HMDS was chosen for the
following study.
Difference between the silylation derivatives
Since a silylation reagent can replace the hydroxyl
groups in UDCA, CDCA, and 7K-LCA, the diffe-
rence between their corresponding silylation deriva-
tives was the key to the subsequent success of the
separation step. As such, silylation was conducted
using standard samples (UDCA, CDCA, 7K-LCA,
and their mixtures at different proportions) as the
silylation reaction substrates and HMDS as the sily-
lation reagent.
The difference between the silylation derivatives of
UDCA, CDCA, and 7K-LCA is presented in Table 1.
The results showed that crystallization was only
observed when UDCA was present in the sample.
When CDCA and 7K-LCA individually or together
were used, no crystallization was observed. The tris-
trimethylsilyl derivative of UDCA has very low solu-
bility in organic solvents, whereas the derivatives of
7K-LCA and CDCA are highly soluble in the same
solvents. This suggested that HMDS can be used to
isolate UDCA from CDCA and 7K-LCA.
Influence of temperature
The silylation reaction is a strongly exothermic reaction.
Thus, temperature could affect the reaction to some
extent. Thus, silylation was conducted over the temperature
range of 20°C to 70°C.Table 1 Difference between the silylation derivatives
Groups UDCA (g) CDCA (g) 7K-LCA (g) Crystallization
1 1.0 0 0 Yes
2 0 1.0 0 No
3 0 0 1.0 No
4 0.8 0.2 0 Yes
5 0.6 0.4 0 Yes
6 0.4 0.6 0 Yes
7 0.2 0.8 0 Yes
8 0.8 0 0.2 Yes
9 0.6 0 0.4 Yes
10 0.4 0 0.6 Yes
11 0.2 0 0.8 Yes
12 0 0.5 0.5 No
Temperature 30°C, 1 g electroreduction product, 10 ml DMF, and 1 g HMDS.The effect of different temperatures on UDCA yield
is shown in Figure 3. In the range of 20°C to 70°C,
the yield of UDCA increased as the reaction
temperature increased. This indicated that the re-
action was an endothermic reaction. When the
temperature was 60°C, the recovery and purity of
UDCA were 95.6% and 97.5%, respectively. The use
of higher temperatures did not lead to further
increases in yield. Consequently, 60°C was chosen for
the following study. Under this temperature, the
reaction was mild and only a small amount of ammo-
nia was produced as a by-product.
Influence of the material ratio
The ratio of reactants needs to be controlled, so silyla-
tion was conducted at different material ratios of elec-
troreduction product, DMF, and HMDS. Table 2
presents the effect of different material ratios on the











1 10.0 1.0 1.0 60.4 92.5
2 10.0 1.0 2.0 99.8 99.5
3 10.0 1.0 3.0 87.6 94.6
4 10.0 2.0 1.0 40.3 90.1
5 10.0 2.0 2.0 45.6 91.2
6 10.0 2.0 3.0 50.8 92.8
7 15.0 1.0 1.0 30.2 93.3
8 20.0 1.0 1.0 26.4 90.6
Temperature 60°C; silylation reagent, HMDS.
Figure 4 The HPLC spectrum of the product and standard spectrum of UDCA. Mobile phase was a mixture of acetonitrile and phosphate
acid buffer (pH 3.0) with a volume ratio of 50:50 at a flow rate of 1.0 ml/min at 25°C. (a) Standard UDCA and (b) product.
Figure 5 The EI-TOF-MS spectra of the derivative of UDCA. (a) The m/z ranged from 0 to 600. (b) The m/z ranged from 605 to 610.
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Table 3 Formula evaluated by multiple mass analysis
Minimum 4.00 −1.5
Maximum 100.00 5.0 5.0 50.0
Mass Relative abundance Calculated mass mDa PPM Double bond equivalents Formula
73.0472 34.67 73.0474 −0.2 −2.1 0.5 C3H9Si
147.0814 30.08 147.0841 −2.7 −18.6 0.5 C6H15O2Si
243.1238 4.43 243.1205 3.3 13.5 7.5 C15H19OSi
350.2317 14.64 350.2277 4.0 11.4 5.0 C20H34O3Si
413.2903 18.26 413.2876 2.7 6.6 7.5 C26H41O2Si
428.3123 28.07 428.3111 1.2 2.9 7.0 C27H44O2Si
446.3178 100.00 446.3216 −3.8 −8.6 6.0 C27H46O3Si
518.3611 45.94 518.3612 −0.1 −0.1 6.0 C30H53O3Si2
608.4114 100.00 608.4112 0.2 0.3 5.0 C33H64O4Si3
Multiple mass analysis, 37 mass(es) processed. Tolerance = 5.0 mDa/double bond equivalents: min = −1.5, max = 50.0. Isotope cluster parameters:
separation = 1.0, abundance = 1.0%.
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DMF/HMDS was 1:10:2 (w/v/v), the recovery and
purity of UDCA were 99.8% and 99.5%, respectively.
With 1 ml HMDS present, the reaction did not complete;
however, when 3 ml of HMDS was used, the silylation
derivative of UDCA did not readily form a crystal
because of the increase of HMDS in the solution. A
comparison of group 2 with groups 4, 5, and 6 showed
that excessive crude UDCA made the reaction system
too viscous to react.
Characterization of the product
After being hydrolyzed and dried, the product was deter-
mined by HPLC, EI-TOF-MS, and FTIR.
Characterization by HPLC
As presented in Figure 4a, the retention time of the
product was 6.3 min and consistent with the stand-
ard HPLC spectrum of UDCA (Figure 4b). In the
range of 0 to 20 mg/ml, the peak area of the stand-
ard UDCA sample and its concentration gave a lin-
ear correlation, with the standard curve of UDCA
being A = 226,034.6C + 18,928.2 (A is the for peak
area, C stands for concentration, R2 = 0.9997). The
sample was run under identical conditions as the
standard UDCA material, and the recovery and pur-
ity were calculated according to an external standard
method.
Characterization by EI-TOF-MS
The EI-TOF-MS spectrum of the tris-trimethylsilyl de-
rivative of UDCA is shown in Figure 5 and Table 3.The spectrum showed its characteristic fragmentation
ions at m/z 608 (100), 593 (14), 518 (45), 446 (100),
428 (28), 413 (18), 350 (14), 243 (30), 147 (30), and
73 (34). The evaluation formulas corresponding to
these fragments are listed in Table 3. As observed,
the ion at m/z 608 corresponds to the tris-
trimethylsilyl derivative of UDCA (C33H64O4Si3). This
result proved that the reaction proceeded and indi-
cated that the active hydrogen atoms of the three
hydroxyl groups on UDCA were substituted by
silylation.Characterization by FTIR
The FTIR spectrum is shown in Figure 6. It indicated
that -Si-O- (839.36 cm−1, 1,080.8 cm−1), -Si-C-
(1,250 cm−1), -C-H (2,867.6 cm−1, 2,943.7 cm−1), and -
CH3 (1,380.0 cm
−1) existed in the structure of the
derivative of UDCA. Thus, the silylation reaction was
confirmed, and the FTIR spectrum of the product is
consistent with the standard FTIR spectrum of UDCA.Conclusions
Ursodeoxycholic acid was purified by silylation
crystallization in this study. By optimizing process
conditions, recovery and purity of ursodeoxycholic
acid was up to 99.8% and 99.5%, respectively. HPLC,
EI-TOF-MS, and FTIR analysis showed that silylation
is a highly efficient purification method of urso-
deoxycholic acid. Compared with previous methods,
the UDCA preparation methods presented herein (i)
gave higher purity and recovery, (ii) avoided cumber-
some procedures, (iii) was more cost efficient, and
Figure 6 The FTIR spectrum of UDCA, derivative of UDCA, and product (KBr pellet). (a) UDCA and derivative. (b) UDCA and product.
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silylation crystallization approach was easy to oper-
ate, economic, and timesaving, and the by-product
(i.e., ammonia) was simple to remove from the reac-
tion medium.
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